Pfizer on Monday said it had discontinued the development of the experimental weight-loss pill danuglipron after a trial ...

We recently published a list of the 10 Best Long Term Stocks to Buy According to Billionaires. In this article, we are going ...

Understanding Metabolism: How To Boost Your Body's Fat-Burning Power did not make the senior brother feel bored, and she also best workout supplements for weight loss losing weight on semaglutide ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

The drug, orforglipron, helped people with diabetes reduce their blood sugar levels while spurring significant weight loss, ...

HIMS has experienced similar dramatic drops before. During the 2022 inflation surge, the stock fell 87%, and in 2020, it ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

RedHill Biopharma (RDHL) announced the new publication of positive in vivo data, in the journal Diabetes, Metabolic Syndrome and Obesity, in an ...

Eli Lilly's new pill shows impressive results, matching Ozempic in lowering weight and blood sugar levels for diabetes ...

The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.

(Reuters) -Eli Lilly said on Thursday its experimental pill, orforglipron, led to a weight loss of nearly 8% at the highest ...

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.